Immunohistochemistry of non-small cell type of lung cancer can be used as a separate prognostic factor?

Aim We aim to assess prognostic significance of immunohistochemistry represented in Napsin A and CK 5/6 in NSCLC, Moreover we aim to correlate histologic patterns of adenocarcinoma with Napsin A expression and identify its prognostic significance. Patients and methods The study was conducted on 130...

Full description

Bibliographic Details
Main Authors: Manar A Abdel Rahman, Eman O Arram, Amr Abdel Hamid
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
Online Access:http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2019;volume=68;issue=4;spage=595;epage=600;aulast=Abdel
_version_ 1818696116144701440
author Manar A Abdel Rahman
Eman O Arram
Amr Abdel Hamid
author_facet Manar A Abdel Rahman
Eman O Arram
Amr Abdel Hamid
author_sort Manar A Abdel Rahman
collection DOAJ
description Aim We aim to assess prognostic significance of immunohistochemistry represented in Napsin A and CK 5/6 in NSCLC, Moreover we aim to correlate histologic patterns of adenocarcinoma with Napsin A expression and identify its prognostic significance. Patients and methods The study was conducted on 130 cases diagnosed pathologically as NSCLC, and then we used Napsin A and CK 5/6 for subtyping them into actual histologic types (108 cases were diagnosed as adenocarcinoma and 22 cases as squamous cell carcinoma, we correlated expression levels of Napsin A and CK 5/6 to different clinicopathological variants. Results Napsin A score 2 was high in age more than or equal 60 years while Napsin A score 3 was high in age less than 50 years also Napsin A score 3 was high in cases with lymph node metastasis, while CK 5/6 was associated with cases without distant metastasis. Conclusion Both Napsin A and CK 5/6 could be used as prognostic and diagnostic markers in NSCLC.
first_indexed 2024-12-17T13:56:15Z
format Article
id doaj.art-34a6dc904d2b4688b3a7620cea7d77c3
institution Directory Open Access Journal
issn 0422-7638
2090-9950
language English
last_indexed 2024-12-17T13:56:15Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Egyptian Journal of Chest Disease and Tuberculosis
spelling doaj.art-34a6dc904d2b4688b3a7620cea7d77c32022-12-21T21:45:54ZengWolters Kluwer Medknow PublicationsEgyptian Journal of Chest Disease and Tuberculosis0422-76382090-99502019-01-0168459560010.4103/ejcdt.ejcdt_94_18Immunohistochemistry of non-small cell type of lung cancer can be used as a separate prognostic factor?Manar A Abdel RahmanEman O ArramAmr Abdel HamidAim We aim to assess prognostic significance of immunohistochemistry represented in Napsin A and CK 5/6 in NSCLC, Moreover we aim to correlate histologic patterns of adenocarcinoma with Napsin A expression and identify its prognostic significance. Patients and methods The study was conducted on 130 cases diagnosed pathologically as NSCLC, and then we used Napsin A and CK 5/6 for subtyping them into actual histologic types (108 cases were diagnosed as adenocarcinoma and 22 cases as squamous cell carcinoma, we correlated expression levels of Napsin A and CK 5/6 to different clinicopathological variants. Results Napsin A score 2 was high in age more than or equal 60 years while Napsin A score 3 was high in age less than 50 years also Napsin A score 3 was high in cases with lymph node metastasis, while CK 5/6 was associated with cases without distant metastasis. Conclusion Both Napsin A and CK 5/6 could be used as prognostic and diagnostic markers in NSCLC.http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2019;volume=68;issue=4;spage=595;epage=600;aulast=Abdelimmunohistochemistrylung cancerprognosis
spellingShingle Manar A Abdel Rahman
Eman O Arram
Amr Abdel Hamid
Immunohistochemistry of non-small cell type of lung cancer can be used as a separate prognostic factor?
Egyptian Journal of Chest Disease and Tuberculosis
immunohistochemistry
lung cancer
prognosis
title Immunohistochemistry of non-small cell type of lung cancer can be used as a separate prognostic factor?
title_full Immunohistochemistry of non-small cell type of lung cancer can be used as a separate prognostic factor?
title_fullStr Immunohistochemistry of non-small cell type of lung cancer can be used as a separate prognostic factor?
title_full_unstemmed Immunohistochemistry of non-small cell type of lung cancer can be used as a separate prognostic factor?
title_short Immunohistochemistry of non-small cell type of lung cancer can be used as a separate prognostic factor?
title_sort immunohistochemistry of non small cell type of lung cancer can be used as a separate prognostic factor
topic immunohistochemistry
lung cancer
prognosis
url http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2019;volume=68;issue=4;spage=595;epage=600;aulast=Abdel
work_keys_str_mv AT manaraabdelrahman immunohistochemistryofnonsmallcelltypeoflungcancercanbeusedasaseparateprognosticfactor
AT emanoarram immunohistochemistryofnonsmallcelltypeoflungcancercanbeusedasaseparateprognosticfactor
AT amrabdelhamid immunohistochemistryofnonsmallcelltypeoflungcancercanbeusedasaseparateprognosticfactor